| Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants NL Welch, M Zhu, C Hua, J Weller, ME Mirhashemi, TG Nguyen, ... Nature Medicine 28 (5), 1083-1094, 2022 | 142 | 2022 |
| Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma P Bandopadhayay, F Piccioni, R O’Rourke, P Ho, EM Gonzalez, ... Nature communications 10 (1), 2400, 2019 | 47 | 2019 |
| Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak KJ Siddle, LA Krasilnikova, GK Moreno, SF Schaffner, J Vostok, ... Cell 185 (3), 485-492. e10, 2022 | 43 | 2022 |
| PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation P Khadka, ZJ Reitman, S Lu, G Buchan, G Gionet, F Dubois, DM Carvalho, ... Nature communications 13 (1), 604, 2022 | 26 | 2022 |
| Multimodal surveillance of SARS-CoV-2 at a university enables development of a robust outbreak response framework BA Petros, JS Paull, CH Tomkins-Tinch, BC Loftness, KC DeRuff, P Nair, ... Med 3 (12), 883-900. e13, 2022 | 19 | 2022 |
| Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts KJ Siddle, LA Krasilnikova, GK Moreno, SF Schaffner, J Vostok, ... Medrxiv, 2021.10. 20.21265137, 2021 | 11 | 2021 |
| The origins and future of sentinel: An early-warning system for pandemic preemption and response Y Botti-Lodovico, P Nair, D Nosamiefan, M Stremlau, S Schaffner, ... Viruses 13 (8), 1605, 2021 | 8 | 2021 |
| Analyzing the impact of a real-life outbreak simulator on pandemic mitigation: An epidemiological modeling study I Specht, K Sani, BC Loftness, C Hoffman, G Gionet, A Bronson, ... Patterns 3 (8), 100572, 2022 | 3 | 2022 |
| MEDB-85. Transcriptional complexes as resistance drivers to BET inhibition A Boynton, L Lupien, R Kumbhani, G Gionet, M Chacon, A Goodale, ... Neuro-Oncology 24 (Suppl 1), i126, 2022 | 1 | 2022 |
| MEDB-73. Lipid metabolism as a therapeutic vulnerability in BET inhibitor-resistant medulloblastoma L Lupien, A Boynton, M Chacon, R Kumbhani, G Gionet, A Goodale, ... Neuro-Oncology 24 (Suppl 1), i123, 2022 | 1 | 2022 |
| Detection of the Recurrent Substitution Q677H in the Spike Protein of SARS-CoV-2 in Cases Descended From the Lineage B. 1.429 CH Tomkins-Tinch, J Silbert, KC DeRuff, KJ Siddle, A Gladden-Young, ... | 1 | 2021 |
| LIPID METABOLISM AS A THERAPEUTIC VULNERABILITY IN BET INHIBITOR-RESISTANT MEDULLOBLASTOMA L Lupien, A Boynton, R Kumbhani, G Gionet, A Goodale, D Root, ... NEURO-ONCOLOGY 23, 214-214, 2021 | | 2021 |
| TAMI-75. LIPID METABOLISM AS A THERAPEUTIC VULNERABILITY IN BET INHIBITOR-RESISTANT MEDULLOBLASTOMA L Lupien, A Boynton, R Kumbhani, G Gionet, A Goodale, D Root, ... Neuro-Oncology 23 (Suppl 6), vi214, 2021 | | 2021 |
| DIPG-53. CHARACTERIZING THE ROLE OF PPM1D MUTATIONS IN THE PATHOGENESIS OF DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGS) P Khadka, Z Reitman, S Lu, G Buchan, R Hartley, H Bear, Y Georgis, ... Neuro-Oncology 22 (Suppl 3), iii297, 2020 | | 2020 |
| MEDU-36. BCL2 FAMILY MEMBERS ATTENUATE RESPONSE OF MYC-DRIVEN MEDULLOBLASTOMAS TO BET-BROMODOMAIN INHIBITION J Clymer, G Gionet, E Gonzalez, G Buchan, K Qian, P Ho, R O’Rourke, ... Neuro-Oncology 21 (Supplement_2), ii110-ii111, 2019 | | 2019 |
| MEDU-37. NEURONAL DIFFERENTIATION AND CELL-CYCLE PROGRAMS MEDIATE RESPONSE AND RESISTANCE TO BET-BROMODOMAIN INHIBITION IN MYC-DRIVEN MEDULLOBLASTOMA P Bandopadhayay, F Piccioni, R O’Rourke, P Ho, E Gonzalez, G Gionet, ... Neuro-Oncology 21 (Supplement_2), ii111-ii111, 2019 | | 2019 |
